This technology, the Center for Adherence Support Evaluation (CASE) Adherence Index, is a simple and effective method for measuring patient adherence to antiretroviral therapy (ART), crucial for monitoring and improving HIV treatment outcomes.
The current gold standard for measuring adherence to antiretroviral therapy (ART) in HIV treatment, including methods like the three-day self-report, often are being time-consuming, requiring staff assistance, and potential inaccuracies due to poor patient recall. These methods, while associated with clinical outcomes, do not effectively balance practicality and accuracy, particularly in routine clinical settings. Addressing these issues is crucial for accurately monitoring and enhancing the effectiveness of ART, thereby improving patient outcomes in HIV treatment.
The CASE Adherence Index simplifies ART adherence measurement with three straightforward questions, assessing patients' medication timing, frequency of missed doses, and recency of the last missed dose. Its design minimizes the need for detailed medication recall, a common limitation in methods like the three-day self-report. The Index's simplicity enables easy implementation in diverse clinical settings without extensive training. Validation testing against established methods demonstrated its strong correlation with key virologic markers, affirming its accuracy and practicality in clinical practice.
IR CU24088
Licensing Contact: Jerry Kokoshka
